Home Other Building Blocks (S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

(S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

CAS No.:
104746-04-5
Catalog Number:
AG00381Q
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.2839
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
99%
1 week
United States
$140
- +
10mg
99%
1 week
United States
$196
- +
25mg
99%
1 week
United States
$321
- +
50mg
99%
1 week
United States
$460
- +
100mg
99%
1 week
United States
$682
- +
Product Description
Catalog Number:
AG00381Q
Chemical Name:
(S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
CAS Number:
104746-04-5
Molecular Formula:
C15H14N2O2
Molecular Weight:
254.2839
MDL Number:
MFCD08460933
IUPAC Name:
(5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide
InChI:
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1
InChI Key:
BMPDWHIDQYTSHX-AWEZNQCLSA-N
SMILES:
O[C@H]1Cc2ccccc2N(c2c1cccc2)C(=O)N
EC Number:
810-248-9
UNII:
S5VXA428R4
Properties
Complexity:
347  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
254.106g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
254.289g/mol
Monoisotopic Mass:
254.106g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
66.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.4  
Literature
Title Journal
Clinical utility of eslicarbazepine: current evidence. Drug design, development and therapy 20150101
The effects of eslicarbazepine on persistent Na⁺ current and the role of the Na⁺ channel β subunits. Epilepsy research 20140201
A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain. Biomedical chromatography : BMC 20120301
Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine. Drug metabolism and disposition: the biological fate of chemicals 20110601
[New drugs in the treatment of adult patients with refractery epilepsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101
Properties